Elective Treatment of Additional and Recurrent Aneurysms in Patients with a Previous Subarachnoid Hemorrhage: A Single-Center Analysis of Complications and Clinical Outcome.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
05 2019
Historique:
received: 18 11 2018
revised: 28 01 2019
accepted: 30 01 2019
pubmed: 23 2 2019
medline: 15 1 2020
entrez: 23 2 2019
Statut: ppublish

Résumé

Subarachnoid hemorrhage (SAH) can be associated with a degree of resulting brain damage and subsequent reorganization of the central nervous system. The aim of this study was to evaluate complication rates and clinical outcome in patients with a previous SAH who were treated for a recurrent or an additional, initially unruptured aneurysm. A retrospective single-center study was conducted for patients who underwent elective treatment by surgical or endovascular means between 2010 and 2018. We compared patients with a previous SAH and without history of SAH in terms of complication rates and functional outcomes (modified Rankin Scale [mRS]). The study population consisted of 337 patients (non-SAH, 270; SAH, 67) who underwent 390 elective procedures for treatment of 443 aneurysms. Procedure-related complications occurred in 13.5% of patients with a previous SAH and in 13.3% of patients without SAH (P = 1.0). At the 6-month follow-up, the morbidity (defined as any increase on the mRS) was comparable between the SAH group (6.7%) and the non-SAH group (7.6%; P = 0.5). Overall favorable outcome (mRS score ≤2) was achieved by 96.6% in the SAH group and 97.3% in the non-SAH group (P = 1.0). Also, in patients with a previous SAH, the choice of clipping or endovascular treatment did not have a significant impact on clinical outcome at the 6-month follow-up. Treatment of recurrent or additional aneurysms in patients with a previous SAH can be performed with acceptable complication rates and morbidity by either surgical or endovascular means.

Identifiants

pubmed: 30794974
pii: S1878-8750(19)30398-5
doi: 10.1016/j.wneu.2019.01.279
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1196-e1202

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Lukas Goertz (L)

Center for Neurosurgery, Department of General Neurosurgery, University of Cologne, Kerpener Strasse, Cologne, Germany. Electronic address: lukas.goertz@uk-koeln.de.

Gerrit Brinker (G)

Center for Neurosurgery, Department of General Neurosurgery, University of Cologne, Kerpener Strasse, Cologne, Germany.

Christina Hamisch (C)

Center for Neurosurgery, Department of General Neurosurgery, University of Cologne, Kerpener Strasse, Cologne, Germany.

Christoph Kabbasch (C)

Department of Neuroradiology, University Hospital of Cologne, Kerpener Strasse, Cologne, Germany.

Jan Borggrefe (J)

Department of Neuroradiology, University Hospital of Cologne, Kerpener Strasse, Cologne, Germany.

Marion Hof (M)

Center for Neurosurgery, Department of General Neurosurgery, University of Cologne, Kerpener Strasse, Cologne, Germany.

Marco Timmer (M)

Center for Neurosurgery, Department of General Neurosurgery, University of Cologne, Kerpener Strasse, Cologne, Germany.

Pantelis Stavrinou (P)

Center for Neurosurgery, Department of General Neurosurgery, University of Cologne, Kerpener Strasse, Cologne, Germany.

Roland Goldbrunner (R)

Center for Neurosurgery, Department of General Neurosurgery, University of Cologne, Kerpener Strasse, Cologne, Germany.

Boris Krischek (B)

Center for Neurosurgery, Department of General Neurosurgery, University of Cologne, Kerpener Strasse, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH